SB-431542, a small molecule transforming growth factor-B-receptor antagonist, inhibits human glioma cell line proliferation and motility
Publication
, Conference
Hjelmeland, M; Hjelmeland, A; Sathornsumetee, S; Herbstreith, MH; Laping, NJ; Bigner, DD; Wang, XF; Rich, JN
Published in: NEURO-ONCOLOGY
October 1, 2004
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
408 / 408
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hjelmeland, M., Hjelmeland, A., Sathornsumetee, S., Herbstreith, M. H., Laping, N. J., Bigner, D. D., … Rich, J. N. (2004). SB-431542, a small molecule transforming growth factor-B-receptor antagonist, inhibits human glioma cell line proliferation and motility. In NEURO-ONCOLOGY (Vol. 6, pp. 408–408). Boston, MA: DUKE UNIV PRESS.
Hjelmeland, M., A. Hjelmeland, S. Sathornsumetee, M. H. Herbstreith, N. J. Laping, D. D. Bigner, X. F. Wang, and J. N. Rich. “SB-431542, a small molecule transforming growth factor-B-receptor antagonist, inhibits human glioma cell line proliferation and motility.” In NEURO-ONCOLOGY, 6:408–408. DUKE UNIV PRESS, 2004.
Hjelmeland M, Hjelmeland A, Sathornsumetee S, Herbstreith MH, Laping NJ, Bigner DD, et al. SB-431542, a small molecule transforming growth factor-B-receptor antagonist, inhibits human glioma cell line proliferation and motility. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 408–408.
Hjelmeland, M., et al. “SB-431542, a small molecule transforming growth factor-B-receptor antagonist, inhibits human glioma cell line proliferation and motility.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 408–408.
Hjelmeland M, Hjelmeland A, Sathornsumetee S, Herbstreith MH, Laping NJ, Bigner DD, Wang XF, Rich JN. SB-431542, a small molecule transforming growth factor-B-receptor antagonist, inhibits human glioma cell line proliferation and motility. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 408–408.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
408 / 408
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences